71 patents
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
26 Jan 23
Nicolas DESROY, Bertrand HECKMANN, Reginald Christophe Xavier BRYS, Agnès Marie JONCOUR, Christophe PEIXOTO, Xavier Marie BOCK
Filed: 18 Jun 21
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
22 Dec 22
David AMANTINI, Reginald Christophe Xavier BRYS, Denis BUCHER, Steve Irma Joel DE VOS, Nicolas DESROY, Agnès Marie JONCOUR, Christophe PEIXOTO, Taoues TEMAL-LAÏB, Amynata TIRERA
Filed: 29 May 19
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
27 Oct 22
Luke Jonathan ALVEY, Denis BUCHER, Nicolas DESROY, Hélène Marie JARY, Christophe PEIXOTO, Taoues TEMAL-LAÏB, Amynata TIRERA, Florence Marie-Emilie BONNATERRE, Béranger DUTHION
Filed: 25 May 20
Utility
Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
27 Oct 22
Luke Jonathan ALVEY, Denis Maurice ANNOOT, Florence Marie-Emilie BONNATERRE, Denis BUCHER, Béranger DUTHION, Hélène Marie JARY, Christophe PEIXOTO, Taoues TEMAL-LAIB, Amynata TIRERA, Nicolas DESROY
Filed: 13 Apr 22
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
22 Sep 22
Oscar MAMMOLITI, Réginald Christophe Xavier BRYS, Gregory John Robert NEWSOME, Marielle Gilles BABEL
Filed: 24 Mar 20
Utility
Prodrug Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
8 Sep 22
The present invention relates to prodrug compounds and their use in the treatment of Cystic Fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Didier Philippe Robert Schils, Sam Bob Corveleyn, Herman Augustinus De Kock, Matthew Beau Dufek
Filed: 27 May 22
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases
28 Jul 22
Taoues TEMAL-LAÏB
Filed: 25 May 20
Utility
Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders.
21 Jul 22
Frédéric Gilbert LABÉGUÈRE, Gregory John Robert NEWSOME, Luke Jonathan ALVEY, Laurent Raymond Maurice SANIÈRE, Stephen Robert FLETCHER
Filed: 12 Nov 21
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
14 Jul 22
Oscar MAMMOLITI, Hélène Marie JARY, Mislav ORSULIC, Denana VRBAN, Marijana KOMAC, Réginald Christophe Xavier BRYS, Rhalid AKKARI
Filed: 24 Mar 20
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Kidney Diseases
30 Jun 22
Katja Els CONRATH, Reginald Christophe Xavier BRYS, Thierry Jean-Claude Marie CHRISTOPHE, Ronald VAN DER GEEST
Filed: 21 Apr 20
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
23 Jun 22
Oscar MAMMOLITI, Réginald Christophe Xavier BRYS, Gregory John Robert NEWSOME, Marielle Gilles BABEL
Filed: 24 Mar 20
Utility
Pyrrolopyrimidine and Pyrrolopyridine Derivatives
2 Jun 22
David AMANTINI, Milan MESIC, Gordon SAXTY, Tanja POLJAK, Ines VUJASINOVIC, Dinko ZIHER, David WITTY, Karl Richard GIBSON
Filed: 3 Sep 21
Utility
Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
31 May 22
The present invention relates to prodrug compounds and their use in the treatment of Cystic Fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Didier Philippe Robert Schils, Sam Bob Corveleyn, Herman Augustinus De Kock, Matthew Beau Dufek
Filed: 2 Jun 20
Utility
Compounds and pharmaceutical compositions thereof for the treatment of diseases
24 May 22
Luke Jonathan Alvey, Denis Maurice Annoot, Florence Marie-Emilie Bonnaterre, Denis Bucher, Béranger Duthion, Hélène Marie Jary, Christophe Peixoto, Taoues Temal-Laib, Amynata Tirera, Nicolas Desroy
Filed: 26 Nov 18
Utility
Pyrazolopyridine Derivatives As Inhibitors of Pask
12 May 22
Stéphane Nicolas Alain BEAUMONT, Xavier Marie BOCK, Daniel COMAS MARTINEZ, Agnès Marie JONCOUR, Frédéric Gilbert LABÉGUÈRE, Miriam LÓPEZ RAMOS, Taoues TEMAL-LAÏB
Filed: 17 Feb 20
Utility
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
11 Jan 22
Frédéric Gilbert Labéguère, Gregory John Robert Newsome, Luke Jonathan Alvey, Laurent Raymond Maurice Sanière, Stephen Robert Fletcher
Filed: 4 May 18
Utility
Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
2 Dec 21
A novel compound able to inhibit JAK is disclosed, this compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6.
Christel Jeanne Marie Menet, Koen Kurt Smits
Filed: 14 Apr 21
Utility
Pharmaceutical Compositions Comprising a Jak Inhibitor
18 Nov 21
Pharmaceutical compositions comprising filgotinib maleate Form I and uses thereof are described herein.
David Alonzo, Bei Li, Dimitrios Stefanidis
Filed: 26 Feb 21
Utility
Methods of Administering Therapy
14 Oct 21
The present invention relates to improved methods of administering compound 1 therapy, involving increased effectiveness of compound 1 by avoiding or contraindicating combined CYP3A4/P-gp inducers, e.g. rifampicin.
Julie DESRIVOT, Florence Sylvie NAMOUR
Filed: 7 Aug 19
Utility
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Fibrosis
14 Oct 21
Oscar MAMMOLITI, Koen Karel JANSEN, Christel Jeanne Marie MENET, Adeline Marie Elise PALISSE, Giovanni Alessandro TRICARICO, Sandy EL BKASSINY, Alexis Patrick Claude JAUNET, Brigitte ALLART, Franck Laurent BREBION, Béranger DUTHION
Filed: 21 Jun 18